HMOX1 : Heme oxygenase 1 HO-1: Heme oxygenase 1 HtrA: high-temperature requirement A ICOS: inducible synergistic co-stimulation molecules IB: inhibitor of NF-B INF-: interferon- IL-1: interleukin-1 IL-6: interleukin-6 IL-11: interleukin-11 ILRs: interleukin receptors IM: intestinal metaplasia I: inhibitor of kappa B kinase iNOS: inducible nitric oxide synthase JAK2: Janus kinase 2 LGR5: leucine rich repeat containing G protein-coupled receptor 5 LPO: lipid peroxidation LPS: lipopolysaccharides MDA: malondialdehyde MAPK: mitogen-activated protein kinase Mek: mitogen-activated protein MMP: matrix-metalloproteinase MQNs: metalquinone networks MPNs: metal-phenol networks
Possible Side Effects While most users tolerate AOD9604 well, mild side effects can occur: Injection site reactions Redness, itching, or mild swelling may appear, especially if rotation of injection sites is inconsistent
This article explores the pharmacology of both agents, potential interactions, who might be considered for concurrent use, and the safety considerations and monitoring requirements that any clinician or patient should understand before combining these treatments
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Our promise Lab-guided bioidentical hormone therapy with personalized pellet dosing and ongoing monitoring